Derek Evans
Amministratore Delegato presso TARGET PharmaSolutions, Inc.
Profilo
Derek Evans is currently the Chief Executive Officer at TARGET PharmaSolutions, Inc. He completed his undergraduate degree at Clarkson University and his MBA at Fox School of Business.
Posizioni attive di Derek Evans
| Società | Posizione | Inizio |
|---|---|---|
TARGET PharmaSolutions, Inc.
 TARGET PharmaSolutions, Inc. Miscellaneous Commercial ServicesCommercial Services TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC. | Amministratore Delegato | 01/11/2021 |
Formazione di Derek Evans
| Fox School of Business | Masters Business Admin |
| Clarkson University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
TARGET PharmaSolutions, Inc.
TARGET PharmaSolutions, Inc. Miscellaneous Commercial ServicesCommercial Services TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC. | Commercial Services |
- Borsa valori
- Insiders
- Derek Evans
